SBC Medical Group Holdings Incorporated SBC
Regular-session close
After hours · Nov 20, 4:00 PM ET
- YTD
- +19.95%
- 1 year
- +66.24%
5D -1.28 (-18.96%)
- Market cap
- 530.32M
- Revenue (ttm)
- 217.54M
- Profit margin
- 27.55%
- EPS (ttm)
- 0.51
- Shares out
- 103.02M
- P/E ratio
- 10.14
- Forward P/E
- 0.52
- YTD return
- +19.95%
- 1-year return
- +66.24%
- Volume
- 377.59K
- Avg volume
- 254.29K
- Open
- 5.50
- Previous close
- 5.60
- Day's range
- 5.03 – 5.53
- 52-week range
- 2.78 – 7.39
- Beta
- 0.12
- Price target
- 11.00 (+112.8%)
- 50-day average
- 6.77
Key statistics
- 200-day average
- 10.90
- Enterprise value
- 620.26M
- Price / sales
- 2.59
- Price / book
- 0.31
- Revenue growth
- 29.50%
- Total cash
- 103.70M
- Total debt
- 29.48M
Fundamental scorecard
15 of 25 checks passed on SBC’s reported financials
15of 25 checks passed
- Value 3 of 5
- Growth 3 of 5
- Profitability 4 of 5
- Financial health 5 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 12, 2025 | Dec 1, 2024 | 2.41 | — | — | — |
About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.
- Sector
- Industrials
- Industry
- Consulting Services
- Country
- United States
- Website
- sbc-holdings.com
News
SBC Medical Group Holdings Incorporated (NASDAQ: SBC) INVESTIGATION ALERT: Portnoy Law Firm Announces Investigation into SBC Medical Group Holdings Incorporated Concerning Potential Securities Fraud
SBC Medical Group Reports Cybersecurity Incidents in Japan
SBC Medical Group Reports Cybersecurity Incidents in Japan
Why SBC Medical Stock Skyrocketed on Friday
12 Health Care Stocks Moving In Friday's Intraday Session
SBC Medical Group Holdings Incorporated (SBC) Q3 2026 Earnings Call Transcript
SBC Medical Group Q3 Earnings Call Highlights SBC Medical Secures Priority Sales Rights For NeuroBrain Dynamics’ Existing Products In Japan And South Korea
SBC Medical Announces Strategic Capital And Business Alliance Agreement With NeuroBrain To Co-Develop Six Medical AI Solutions Targeting Revenue Expansion, Cost Reduction
SBC Medical Group Holdings Reports Third Quarter 2026 Financial Results
Your note
Sign in to keep a note on SBC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ZUU CO. LTD. | Beneficial Owner of more than 10% of a Class of Security | Sale | Sep 18, 2024 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Tuttle Capital Management, LLC | 0.01% | 14,369 | 78.60K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.00% | 21 | 114 | Sep 29, 2024 |
| UBS Group AG | 0.00% | 3,210 | 17.56K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.00% | 1,716 | 9.39K | Oct 30, 2024 |
